Loading
Adheris Health Limited Stock: price and insider trades · Australia
1 insider bought €6,126 of shares over the last 90 days, the latest filed 01 Oct 2026.
Adheris Health Limited: what insiders have been doing
Adheris Health Limited is a listed company. Its directors and officers file their transactions with ASX. In the past year (18 October 2025 to 18 October 2026), 8 filings came from 7 insiders.
The flow runs one way only: 2 insiders bought (2 purchases totalling €10k) and nobody sold on the market. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. On the buying side, the filings list 2 senior executives among the declarants. One trade stands out by size: a purchase of €6,126 from Catherine (Kate) Jane Hill, disclosed on 1 October 2026, or 0.098% of market capitalisation.
The most recent open-market purchase was published on 1 October 2026, 17 days ago.
With 8 filings in twelve months, the company is more active than the median of 3 filings across the 2,222 companies we follow on the same exchange. Our records for Adheris Health Limited go back to 2026, with 2 purchases and no sales on the open market in total.
Source: insider filings from ASX. Past trades are no guide to future returns.
Insider Decl.
8
Thresholds
n/a
Buy Volume
€10,116
2 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleCatherine (Kate) Jane Hill1 buy
John Ciccio1 buy
Since the insiders bought
- +8.5%Entry A$0.02 · Close at T+90 A$0.02
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 4,998 of 24,148 companies
66.4
score / 100
Value93
Quality40
FCF yld38%
Earn yld8.9%
EV/EBITDA3.1x
ROE-178%
Gross mgn61%
Net mgn0.6%
Debt/EBITDA1.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2024FY ended June 2024 · cache
A$0.01
Analyst consensus
Income statement
RevenueA$122.1M
Gross profitA$74.2M61% margin
EBITDAA$7M6% margin
Net incomeA$792.1k-12.7% margin
Valuation
P/Book1.1x
Beta1.05
Balance sheet & cash
Market capA$8.9M
Total debtA$12.6M
Free Cash FlowA$3.4M
Debt / Equity2%
Profitability & ownership
ROE-177.9%
ROA-35.8%
% insiders31.1%
% institutions39.6%
Last declaration on 2 October 2026
Declarations8 total
ShareASXASX:2924-03143843-6A1347391
ShareASXISIN AU0000437493ASX:2924-03143385-6A1347277
1,000,000 shares@ A$0.010.098% mcap100.0% of flowShareASXISIN AU0000437493ASX:2924-03143146-6A1347168
Canonical exit: 30 Dec 2026 (T+90)
ShareASXASX:2924-03116926-6A1336818
●
ShareASXISIN AU0000437493ASX:2924-03106480-6A1331987
ShareASXISIN AU0000437493ASX:2924-03106479-6A1331986
ShareASXISIN AU0000437493ASX:2924-03103675-6A1330906
323,541 shares@ A$0.020.63% mcap100.0% of flowShareASXASX:2924-03089232-6A1325134
Canonical exit: 10 Aug 2026 (T+90)
8 of 8 declarations
About Adheris Health Limited
Adheris Health Limited is a company listed on the XASX, specializing in the healthcare sector. It focuses on developing solutions to improve patient adherence to medical treatments.
